Abstract Objective: The purpose of our study was to investigate whether adding diffusion weighted imaging to dynamic contrast-enhanced MRI could improve the diagnostic performance of breast MRI. Materials and methods: This retrospective study included 86 women with 93 primary and postoperative breast lesions detected on DCE-MRI who underwent subsequent biopsy. The diagnostic performance was calculated for DCE-MRI alone, combined DCE-MRI and quantitative DWI, and for quantitative DWI alone. Results: Of the 93 lesions, 42 were benign and 51 malignant (5 DCIS, 41 IDC, 2 ILC, 3 NOS). Both DCIS (mean ADC = 1.17 ± 0.12 · 10 À3 mm 2 /s) and IDC (mean ADC, 0.98 ± 0.14) exhibited lower mean ADC values than benign lesions (ADC value = 1.72 ± 0.36). Applying an ADC cutoff value of 1.33 increased the specificity and PPV of DCE-breast MRI from 59.5% and 75% to 78.5% and 83.3%, respectively. The specificity and PPV for quantitative DW-MRI alone (73.5% and 83.3%) were close to those broken out from the combined use of DCE and quantitative DW-MRI. However, the sensitivity and NPV of DWI remains lower than that of DCE-MRI.
Introduction
Magnetic resonance imaging (MRI) is increasingly used as an important tool for detecting and characterizing breast lesions and in the preoperative assessment of breast cancer to evaluate local/regional extent of disease and to find additional lesions (1, 2, 7) . Dynamic contrast-enhanced breast MRI (DCE-MRI) has been reported to have high sensitivity in detecting breast cancer -reportedly as high as 88-100%, but its specificity may be more modest -in the range of 68-96% (4) (5) (6) 8) . The diagnosis in DCE-MRI is based primarily on contrast material enhancement velocity, enhanced morphology and delayed phase kinetics (washout, plateau, and persistent) interpreted simultaneously. Breast carcinomas generally show a faster and stronger signal intensity increase after a bolus injection of Gadolinium based contrast agent than most benign lesions and normal breast tissue. However, the specificity with which contrast material enhancement can be used to predict malignancy remains variable. The limitation of specificity of DCE-MRI observed in several studies can be attributed to the fact that several benign breast lesions including fibroadenomas can also show strong contrast agent enhancement such that the signal intensity versus time curves considerably overlap those of breast carcinomas (8, 9) .
In the preoperative assessment of breast carcinoma, MRI has been shown to be superior to mammography, ultrasound and clinical examination in determining tumor size and in detecting multi-focal and multi-centric disease [10] . Currently, importance is also being given to assessment of intra-ductal spread. This is because intra-ductal spread is considered one of the greatest risk factors for recurrence following breast conserving therapy (11) .
Currently one of the most important indications for MRI is the differential diagnosis between cancer recurrence and surgical scar. In fact, breast MRI has become a common practice in the evaluation for recurrence of breast cancer. Both surgery and radiation can cause scarring with architectural distortion of the breast, which makes assessment of local recurrence difficult by means of clinical examination, mammography, and ultrasound. Post-treatment changes can mimic malignancy or obscure locally recurrent breast cancer (2, 5) . For these reasons, breast MRI is a useful tool in the evaluation of such patients.
Several strategies have evolved to improve the specificity of breast MRI. One approach has been to emphasize the morphology of the lesion (7), other strategies are pharmacokinetic analysis of the time-signal-intensity curves and the application of a T2 * weighted first pass perfusion sequence with high temporal resolution to help differentiate benign lesions such as fibroadenomas from invasive carcinoma. While passing through the capillary network, a bolus injection of paramagnetic contrast medium produces local field inhomogeneity between the intra-and extravascular compartments, and this susceptibility difference can be detected by a series of T2 * -weighted gradient-echo images (14) .
Diffusion-weighted MRI produces in vivo images of biological tissues weighted with the local micro-structural characteristics of water diffusion (14) . Diffusion is the result of thermal fluctuations with a random pattern and this is often referred to as ''Brownian motion'' (15, 16) . The Brownian motion of protons in bulk water produces the signal in DWI. The apparent diffusion coefficient (ADC) is a calculated value used to quantify Brownian motion; it includes Brownian motion (incoherent motion) and capillary blood circulation (coherent motion), but coherent motion is affected less using high diffusion sensitizing factors (b-values) (17, 13) . Decreased movement of molecules in the tissue correlates with a low ADC value. The lower ADC values of malignant tissues are primarily attributed to higher cell density causing increased restriction of the extracellular matrix and increased fraction of signal coming from intracellular water (1, 18, 20) .
With new diagnostic criteria based on a combination of DCE-MRI and DWI, we may be able to correctly diagnose breast lesions that show equivocal findings from morphologic and kinetic data analysis alone. Based on the same concepts, quantitative DWI could be used as an additional tool, in association with the morphological and dynamic sequences, to improve the evaluation of the scar area in patients with suspected recurrence (12, 5) .
The purpose of this study was to verify the diagnostic accuracy of a combination of DCE-MRI and quantitative DWI in the characterization of enhancing masses on breast MRI and to improve the evaluation of the scar area in patients with suspected recurrence.
Materials and methods

Patients
During the period from September 2007 to January 2010, 91 patients were referred to the MRI unit of Ain Shams University School of Medicine for clinically indicated bilateral breast MRI. The clinical indications included workup of clinically palpable masses and evaluation of local/regional extent of disease in 56 newly diagnosed breast cancer patients and confirmation of clinically suspicious local recurrence at the operative scar after breast conservation-surgery in 35 cases. All patients had undergone breast ultrasonography and the lesions were accordingly assigned as BIRADS category 3, 4 or 5 [31, 32] . These findings included irregular or lobulated hypoechoic mass ± ill defined or spiculated margins ±posterior acoustic shadowing, focal area of architectural distortion, unstable scar on successive examinations, associated mastitis, and/or mammographically detected segmentally and/or ductally arranged suspicious microcalcifications. Five patients were excluded from the study because of absence of enhancing lesions on DCE-MRI and technical problems with the DWI sequences resulting from patient motion or inadequate fat suppression. The study cohort therefore included 86 subjects ranging in age from 24 to 80 years (mean age, 52 ± 11 years); including 53 primary and 33 postoperative cases.
MRI technique
The MR examinations were performed either before core-needle biopsy or at least 2 weeks after core-needle biopsy to avoid the abnormal enhancement pattern caused by local inflammatory reaction following biopsy. In the cases of surgical biopsy, MRI examinations were performed no more than 2 weeks before surgery. MR imaging was performed using the Intera 1.5T (Philips Medical Systems, The Netherlands). All patients were placed prone with their breasts within a standard 4-channel, receive only, breast coil covering both breasts.
Each MRI examination included (1) sensitivity encoding, with use of a parallel imaging reduction factor of 2; acquisition time: 207 s. ADC maps were generated from the diffusion-weighted images. (4) Lastly the dynamic images with a fast field echosequence were sequentially obtained before and at 0, 90, 180, 270 and 360 s after intravenous bolus injection of Gadolinium diethylenetiamine pentaacetic acid (total dose, 0.1 mmol/kg of body weight) using a flow rate of 2 ml/s into the antecubital vein with a 18-20 G needle followed by a flush of 20 ml of saline solution with 10 s of time delay before beginning image acquisition. The imaging parameters were as follows: TR/TE, 4.9/ 2.5; flip angle, 10°; FOV, 400 mm; matrix, 256 · 196; thickness, 6 mm; acquisitions 1; acquisition time: 90 s. Sagittal reformations from the 3D data set of the T1W DCE images were performed. Dynamic images were transferred to a workstation (Advantage Windows 4.1). With post-processing software that showed signal intensity changes over time the region of interest (ROI) was selected and a dynamic curve was obtained.
Interpretation of MR findings
MRI images were analyzed by two readers each blinded with three and half years experience in breast MR imaging who identified suspicious areas of enhancement and categorized them as masses and non-mass enhancement. Morphological assessment was based on the American College of Radiology Breast Imaging Reporting and Data System (BIRADS) lexicon (1, 19) : shape (round, oval, lobular, or irregular), margin (smooth, irregular, or spiculated), and enhancement pattern (homogeneous, heterogeneous, rim enhancement, dark internal septa, enhancing internal septa, or central enhancement) of the tumor mass. For non-mass enhancement, the distribution (diffuse, regional, segmental or ductal) and enhancement pattern (homogenous, heterogeneous, stippled, reticular, dendritic, or clumped) were evaluated. Other findings were analyzed including: tumor size as defined by the longest dimension on DCE-MRI, time-signal-intensity curve pattern on dynamic contrast-enhanced images, and the ADC value derived from an ADC map.
Dynamic MR imaging analysis
Regions of interests (ROIs) were placed to evaluate the enhancement pattern that was demonstrative of the highest visual enhancement. Thereafter, time-signal-intensity curves were generated. Kinetic curve type assessment was performed according to the BIRADS MR imaging guidelines. Time-signal-intensity curve patterns were categorized into three types using data obtained during the last four phases of dynamic imaging: The persistent pattern (type I), the plateau pattern (type II), and the washout pattern (type III), in which the signal intensity decreases at least 10% after reaching the highest point of its initial increase during the delayed phase. MRI was considered negative in the absence of areas of suspicious enhancement and patients were managed with follow-up alone without biopsy.
Diffusion MRI analysis
In all cases the ADC value was measured in the area with pathological enhancement and/or in the area of prolonged scar enhancement. The ROI was drawn freehand to include the area of hyperintensity, encompassing as much of the abnormality as possible while staying within the border of the hyper-intense region. Care was taken to avoid regions of high T2 signal within a lesion, such as cyst, hematoma, necrosis or seroma by verifying the ROI against the T2-weighted b = 0 s/mm 2 image to reduce the T2 shine-through effect. The mean ADC of the voxels in the ROI was calculated according to ADC = (À1/b2Àb1) ln(S2/S1), where S1 and S2 are the signal intensities in the regions of interest (ROI) obtained with different gradient factors (b-values of 0 and 1000 s/ mm 2 ). As a reference, we used the normal-appearing fibroglandular tissue that showed homogeneous signal intensity on both the ADC map and the T1-weighted images. To place the ROI for both time-signal-intensity curve construction and ADC measurement in the same area, we used reference lines on an image viewer.
The final diagnoses were based on the histopathology results of core-needle biopsy. According to histopathology results, we categorized the breast lesions into seven groups: (1) invasive ductal carcinoma (IDC), (2) DCIS, (3) invasive lobular carcinoma (ILC), (4) carcinoma NOS, (5) high risk lesions, (6) benign lesions, and (7) postoperative benign changes. The ADC values were then averaged. We compared the ADC values among the various malignant and benign lesions, the scar tissue and the normal-appearing fibroglandular tissue.
Statistics
Determination of cutoff level for the ADC value:
To determine the ability of the ADC value to enable the differentiation of malignant from benign breast lesions, the feasible ADC value threshold was determined by using a receiver operating characteristic (ROC)-based positive test for all lesions. Receiver operating characteristic analysis was used to evaluate the effectiveness of the absolute ADC value in the characterization of benign versus malignant breast lesions. T-tests were used for analyzing the differences of the mean ADC values of the IDC, ILC, DCIS, benign lesions and normal-appearing fibroglandular tissue. 2. A diagnostic validity test for the DW-MRI was performed (Table 5 ) and included: the diagnostic sensitivity, the diagnostic specificity, the predictive value for a +ve test (PPV), and the predictive value for a Àve test (NPV). 3. Multivariate analysis: We selected covariates for multivariate analysis among the variables including margin of mass, internal mass enhancement, TIC pattern and absolute ADC values (equal, smaller or larger than feasible ADC cutoff value) of all mass and non-mass like lesions. All these covariates are listed in Table 4 . 4. Chi-square test was used to study the association between each two variables as regards the categorized data. 5. Z-test for comparison between two proportions as regards univariant categorized data.
We calculated P-values of the each predictor variables. The probability of error at 0.05 was considered significant, while at 0.01 and 0.001 are highly significant.
All data were analyzed using the PASW statistical software package (V. 18.0, IBM Corp, USA, 2010).
Results
Conventional MRI imaging parameters
Sixty-two enhancing lesions were detected on DCE-MRI in 53 newly presenting patients. Using a combination of morphologic and dynamic findings 48 of these lesions were assigned a final BIRADS assessment of 4 a, b, and c (low, intermediate, and moderate suspicion) or 5 (highly suggestive of malignancy) and 14 lesions were categorized as BIRADS 2 or 3 (benign or probably benign). DWI was acquired successfully in all these cases and core-needle or excisional biopsies were taken after MRI. The types of contrast enhancement included four foci (three benign and one malignant), 52 masses (19 benign and 33 malignant), and six non-mass enhancements (three benign, three DCIS). Lesion sizes, as defined by the longest dimension on DCE-MRI, ranged from 0.6 to 5.4 cm (median, 1.2 cm). The final histopathological outcomes were as follows: 37 (60%) malignant, three high risk, and 22 (40%) benign lesions. The malignant lesions included: 28 IDC, two ILC, five DCIS, and two carcinoma NOS. The high risk lesions were three atypical ductal hyperplasia (ADH) and the 22 benign lesions included: 13 fibroadenomas, four fibrocystic disease, three focal adenosis, one case of focal fibrosis and one case of mastitis. The results of tissue sampling are listed in Table 1 . The significantly frequent morphologic MR findings among the malignant lesions were lobular or irregular shape, irregular or spiculated margin, heterogeneous or rim enhancement, ductal, linear and segmental distribution of non-mass enhancement and washout and plateau time intensity curve (TIC) pattern (e.g. Figs. 2 and 3) whereas oval shape, smooth or gently lobulated margin, homogeneous internal enhancement, and persistent TIC pattern were the significantly frequent findings in benign lesions (e.g. Fig. 4) . The MR findings of all lesions are summarized in Table 2 .
In nine of the 33 cases with suspected local recurrence no enhancement was identified on DCE-MRI and these were considered benign. In the remaining 24 cases, 31 enhancing lesions were identified (15 masses and 16 non-mass enhancements). DCE-MRI was considered positive in 15 lesions based on a combination of morphologic and kinetic findings. According to histopathological results, 14 of the enhancing lesions where true recurrence in the region of scarring and all recurrences were invasive (13 IDC and one invasive carcinoma NOS (true +ve). See Fig. 6 for example. One DCE positive proved to be scar tissue (false +ve). 11 lesions were negative based on combination of morphological and dynamic findings and tissue sampling revealed benign tissue in these 11 (six scar tissue and five liponecrosis (true Àve). In the remaining five lesions DCE-MRI was inconclusive due to mismatch between morphologic and kinetic findings. All these lesions were benign on tissue sampling (four of them were scar tissue devoid of atypical cells and one case turned out to be liponecrosis. These five inconclusive lesions were considered false +ve by DCE-MRI.
Diffusion-weighted and quantitative ADC imaging characteristics
Fifty-eight of the 62 primary enhancing lesions, including both carcinomas and benign lesions, were hyperintense on DWI much more conspicuous at b = 0. Four lesions were isointense to surrounding tissue and were not easily identified on DWI (DW Àve). The isointense lesions included two foci (each In all postoperative cases with positive recurrence in or near the operative scar (14 lesions), DWI showed areas of hyperintensity corresponding to the enhancing lesions. In four of the 12 benign enhancing postoperative lesions (liponecrosis or scar), DWI did not show areas of hyperintensity corresponding to the lesions. All lesions, with inconclusive DCE-MRI findings (5) were hyperintense on DWI.
The ADC values were estimated only for the DW hyperintense lesions (58 primary and 27 postoperative lesions). The À3 mm 2 /s and for normal-appearing breast parenchyma the mean ADC = 1.51 ± 0.29 · 10 À3 mm 2 /s. The mean ADC value for scar tissue = 1.6 ± 0.2 · 10 À3 mm 2 /s and for liponecrosis = 2.1 ± 0.12 · 10 À3 mm 2 /s. (Table 3 ). Diagnostic validity test showed that the best cutoff value for ADC to discriminate between malignant and benign was 1.33 · 10 À3 mm 2 /s below which lesions are likely malignant and above which likely benign (Fig. 1) . Using this cutoff ADC value, in addition to all values of DCE-MRI (including unenhanced morphology, unenhanced signal values, enhanced morphology and kinetics, a sensitivity = 88.2% (ability to discriminate malignant) and a specificity = 78.6% (ability to discriminate benign) with predictive value for a negative test (NPV) of 84.6% (% of true negative among all negatives) and predictive value for a positive test (PPV) of 83.3% (% of true positive among all positives). Table 5 summarizes the diagnostic validity of dynamic contrast MRI alone and that after the addition of ADC cutoff values.
Despite some overlap in values between benign and malignant lesions, the 51 malignant lesions exhibited significantly lower ADC values than the 42 benign lesions. Nine benign lesions (seven primary and two postoperative lesions), however, exhibited ADC values below this cutoff level and were therefore suspicious by quantitative DWI. An example of such a false +ve positive DW finding is shown in (Fig. 5) . Six When diffusion weighted imaging characteristics including qualitative (iso or hyperintense) and quantitative ADC values were used exclusively a sensitivity of 88.2% and a specificity of 73.5% with NPV of 80.64% and PPV of 83.3% were concluded. Table 6 summarizes the diagnostic validity of diffusion weighted imaging alone.
Discussion
Breast MRI is a widely accepted diagnostic approach for detecting and evaluating breast lesions (5). For women with management of patients with operable breast cancer. It is also currently used to evaluate response to neoadjuvant chemotherapy for breast cancer (21, 22) .
The detection and quantification of recurrent tumor in or adjacent to the operative scar is another important clinical question if breast conservation is being considered. Followup of patients after conservative treatment frequently includes periodic clinical examination and mammography every 6 months during the first 2 years and every year thereafter. The expected alterations in the treated breast include the surgically caused scar formation and deformity as well as radiation induced inflammation and fibrosis. The ability of mammography to show a cancer in the post-treatment breast is compromised by the increased density and surgical deformity often present. In large mammographic surveillance series in the post-treatment setting sensitivity fell to 64-71% (1). Diagnostic problems are also encountered with ultrasonography because of hypoechoic areas, architectural distortion, and shadowing arising from the scar tissue (23) . In a 2006 multicenter study Schnall et al. (2) reported that the best predictive parameters for malignancy were lesion shape, margin, signal intensity, enhancement pattern, and kinetic curve type. Our results indicated that the same aspects of DCE-MRI are the best predictors of malignancy. The observed increased enhancement within primary and recurrent tumors (compared with normal breast tissue) is a reflection of the leakiness of the neo-vascularity induced by malignant tissues. The majority of surgical scars more than 6 months after surgery do not enhance significantly while almost all malignancies do enhance significantly. Patients of our series were examined when the MR changes related to the development of early reactive fibrosis would be considered to have resolved. Evaluation of the speed of enhancement in DCE-MRI appears promising in aiding differentiation between benign and malignant lesions as well as differentiation of benign scar from recurrent cancer.
Recently there have been several reports concerning the usefulness of adding quantitative DWI to DCE-MRI in differentiating benign and malignant breast lesions (15, 17, (21) (22) (23) (24) . However, to our knowledge, there has only been a single recent study by Rinaldi et al. (24) analyzing the value of combining DWI and DCE-MRI for improving the diagnostic accuracy in patients with suspected recurrence at the scar site.
Generally, in biologic tissues, ADC values are affected by microscopic motion including both the molecular diffusion of water (incoherent motion or Brownian motion) and the blood microcirculation in the capillary network (coherent motion). Because of the extensive micro-vessels in malignant breast tumor, the ADC value can be strongly affected by perfusion when the b-value is small (16, 25, 26) /s using b = 1000 by Guo et al. (18) . The reason for these discrepancies can be explained by the ADCs being calculated using linear regression analysis and analysis of the natural log of the signal intensity versus the different gradient factors or b-values (16, 27) . We applied sensitizing diffusion gradients with b-values of 0 and 1000 s/mm 2 , in accordance with Marini et al. (17) . Because coherent motion affects the ADC less with a high b-value such as 1000 s/mm 2 such that we could obtain diffusion effects as measured by ADC calculation without significant contamination from coherent motion effect.
Our results showed that the mean ADC of malignant lesions is 0.98 · 10 À3 mm 2 /s, which correlates well with the above-mentioned results from the literature. We compared the ADC values of breast lesions to that of normal fibroglandular tissue as recommended by Park et al. (28) because ADC values are variable depending upon the upper b-value used. Statistically significant differences were found between the mean ADC values of IDC and DCIS and that of normal fibroglandular tissue (p 6 0.05). Also the mean ADC values of malignant lesions were statistically different from those of benign tumors and scar tissue.
Rubesova et al. (13) and Sinha et al. (15) have shown promising differences between benign and malignant lesions through a multivariate combination of ADC and DCE-MRI features. They reported a cutoff level between benign and malignant lesions for highest sensitivity and specificity of 1.13 and 1.1 · 10 À3 mm 2 /s, respectively. In our study we assumed an ADC cutoff level of 1.33 · 10 À3 mm 2 /s. By applying this cutoff level for malignant lesions, the specificity and PPV of breast MRI was increased from 59.5% and 75% using DCE-MRI alone to 78.6% and 83.3%, respectively, with the addition of quantitative DWI. Applying this cutoff value could have prevented biopsy in 33 (78.5%) of 42 benign lesions. Partridge et al. (30) by applying an ADC threshold of 1.81 · 10 À3 mm 2 /s for 100% sensitivity produced a PPV of 47% versus 37% for DCE-MRI.
Interestingly enough the diagnostic specificity broken out when quantitative DW-MRI was used alone (73.5%) was not significantly lower than that calculated using a combination of DCE-MRI and DW-MRI (78.5%). Even more the PPV obtained from the exclusive use of quantitative DW-MRI was identical to that obtained when both DCE-MRI and quantitative DW-MRI were used together. Several limitations arose from our study: (1) Context bias (a large number of malignant lesions relative to benign lesions). We usually perform MRI for suspicious lesions for the purpose of preoperative assessment of suspected breast cancer. Therefore, because of a high pretest probability of malignancy for our population we did not obtain a sufficient number of benign breast lesions for optimal statistical analysis. (2) A false negative rate of 6.4% emerged through the application of an ADC cutoff value that was not existing by using the DCE-MRI criteria alone. This resulted in a lower sensitivity and NPV when adding quantitative DW-MRI to DCE-MRI or when using quantitative DW-MRI alone (88.2% and 80.64%, respectively). (3) Even though we attempted to obtain meaningful ADC values in purely normal fibroglandular tissue, in some regions malignant tissue was inter mixed with normal tissue, this was especially problematic in the cases with intra-ductal spread of breast lesions. (4) We could not detect some satellite nodules. A previous report demonstrated that nodules less than 1.0 cm in diameter are not detectable on DWI (25) . (5) Some portion of false positives seems inevitable. However, in our series, the 22% rate of false positivity using DCE-MRI alone decreased to 14% if we added two DWI sequences; in fact for all inconclusive lesions based upon DCE-MRI alone, which were benign at biopsy, ADC was >1.33 mm 2 /s .
Conclusion
We can conclude from this study that the addition of quantitative DW-MRI to DCE-breast MRI would improve its diagnostic specificity and would prevent a large number of unnecessary biopsies. More important is that, despite its relatively low sensitivity, DW-MRI can still be considered sensitive enough with a sufficiently high specificity to be used as a first round for screening of breast lesions perhaps in combination with other non contrast sequences (e.g. DTI) preferably in other populations with lower pretest probability of malignancy.
